Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $6,201 - $7,950
-105 Reduced 0.1%
103,354 $7.65 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $3.21 Million - $4.82 Million
-48,690 Reduced 32.0%
103,459 $7.06 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $2.26 Million - $3.43 Million
36,035 Added 31.03%
152,149 $14.3 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $5.48 Million - $8.22 Million
116,114 New
116,114 $7.87 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $348,016 - $744,995
9,773 Added 33.39%
39,038 $1.54 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $3.28 Million - $4.7 Million
-56,984 Reduced 66.07%
29,265 $2.05 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $11,237 - $15,605
155 Added 0.18%
86,249 $6.71 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $3.75 Million - $5.15 Million
41,523 Added 93.16%
86,094 $8.22 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $321,160 - $477,556
-3,429 Reduced 7.14%
44,571 $5.54 Million
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $4.52 Million - $6.01 Million
38,759 Added 419.42%
48,000 $6.33 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $920,496 - $1.31 Million
9,241 New
9,241 $1.22 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $263,291 - $725,544
-6,947 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$77.66 - $99.74 $461,921 - $593,253
-5,948 Reduced 46.13%
6,947 $642,000
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $206,585 - $280,012
2,286 Added 21.55%
12,895 $1.17 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $298,157 - $393,191
3,331 Added 45.77%
10,609 $1.25 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $233,912 - $364,191
3,774 Added 107.71%
7,278 $630,000
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $196,364 - $289,640
3,504 New
3,504 $221,000
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $2.88 Million - $4.81 Million
-59,651 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $2.26 Million - $4.17 Million
59,651 New
59,651 $3.57 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $2.31 Million - $3.34 Million
-58,008 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $2.82 Million - $3.68 Million
-60,740 Reduced 51.15%
58,008 $3.05 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $4.4 Million - $5.6 Million
118,748
118,748 $5.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.33B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.